Institut Kassab d'Orthopédie
8
0
0
3
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 8 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 3 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (8)
Quadratus Lumborum Block for Pediatric Hip Surgery
Role: collaborator
IPACK Block After Total Knee Arthroplasty
Role: collaborator
Ultrasound Percapsular Nerve Group Block VS Fascia Iliaca Block for Hip Fracture
Role: collaborator
Performance of EOS Imaging System in the Assessment of Spondyloarthritis Structural Changes Compared With Standard Radiography
Role: collaborator
IV Iron in Association With Tranexamic Acid for Hip Fracture
Role: lead
Continuous Spinal Anesthesia With Hypobaric Bupivacaine to Preserve Hemodynamics in Elderly
Role: lead
Continuous Adductor Canal Block for Total Knee Arthroplasty Analgesia
Role: lead
US Guided Axillary Block With Only One Injection
Role: lead
All 8 trials loaded